148 related articles for article (PubMed ID: 36332387)
1. Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases.
Liu M; Li Z; Ouyang Y; Chen M; Guo X; Mazhar M; Kang J; Zhou H; Wu Q; Yang S
Phytomedicine; 2023 Jan; 108():154503. PubMed ID: 36332387
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology-based approach to understand the effect and mechanism of Danshen against anemia.
He S; Wang T; Shi C; Wang Z; Fu X
J Ethnopharmacol; 2022 Jan; 282():114615. PubMed ID: 34509606
[TBL] [Abstract][Full Text] [Related]
3. Combination of ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry and network pharmacology to reveal the mechanism of Shengyu Decoction for treating anemia.
Hu Y; Sun H; Yan G; Zhang X; Guan Y; Li D; Wang X
J Sep Sci; 2023 Feb; 46(3):e2200678. PubMed ID: 36437813
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the mechanism of Dachengqi Decoction treating colorectal cancer based on the analysis method of " into serum components -action target-key pathway".
Yin FT; Zhou XH; Kang SY; Li XH; Li J; Ullah I; Zhang AH; Sun H; Wang XJ
J Ethnopharmacol; 2022 Jul; 293():115286. PubMed ID: 35413412
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of 'Invigorating Qi and Promoting Blood Circulation' Drug Pair Ginseng-Danshen on Treatment of Ischemic Heart Disease Based on Network Pharmacology.
Xin GJ; Zhao YW; Li LM; Jia FF; Han X; Li L; Guo H; Meng HX; Fu JH; Liu JX
Chin J Integr Med; 2021 Jun; 27(6):440-445. PubMed ID: 33420585
[TBL] [Abstract][Full Text] [Related]
6. Qualitative analysis of the roots of Salvia miltiorrhiza and Salvia yunnanensis based on NIR, UHPLC and LC-MS-MS.
Ni L; Zhang F; Han M; Zhang L; Luan S; Li W; Deng H; Lan Z; Wu Z; Luo X; Mleczko L
J Pharm Biomed Anal; 2019 Jun; 170():295-304. PubMed ID: 30951995
[TBL] [Abstract][Full Text] [Related]
7. Integration of UPLC-QE-MS/MS and network pharmacology to investigate the active components and action mechanisms of tea cake extract for treating cough.
Lin C; Liu Z; Chen J; Wang X; Zhang R; Wu L; Li L
Biomed Chromatogr; 2022 Oct; 36(10):e5442. PubMed ID: 35781817
[TBL] [Abstract][Full Text] [Related]
8. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
9. The integrated study on the chemical profiling and in vivo course to explore the bioactive constituents and potential targets of Chinese classical formula Qingxin Lianzi Yin Decoction by UHPLC-MS and network pharmacology approaches.
Gao WY; Si N; Li ML; Gu XR; Zhang Y; Zhou YY; Wang HJ; Wei XL; Bian BL; Zhao HY
J Ethnopharmacol; 2021 May; 272():113917. PubMed ID: 33609729
[TBL] [Abstract][Full Text] [Related]
10. Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy.
Liu M; Yuan G; Luo G; Guo X; Chen M; Yang H; He F; Yang T; Zhang X; Wu Q; Zhou H; Yang S
Evid Based Complement Alternat Med; 2022; 2022():7578055. PubMed ID: 35722148
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
12. Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.
Chen W; Chen G
Curr Pharm Des; 2017; 23(34):5125-5135. PubMed ID: 28828985
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic material basis of Daqinglong Decoction: based on serum pharmacochemistry and network pharmacology].
Yuan M; Sun GD; Liu HS; Huo JH; Wang WM
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3876-3886. PubMed ID: 35850846
[TBL] [Abstract][Full Text] [Related]
14. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
15. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
[TBL] [Abstract][Full Text] [Related]
16. Danshen-Gegen decoction exerts proliferative effect on rat cardiac myoblasts H9c2 via MAPK and insulin pathways.
Fong CC; Wei F; Chen Y; Yu WK; Koon CM; Leung PC; Fung KP; Lau CB; Yang M
J Ethnopharmacol; 2011 Oct; 138(1):60-6. PubMed ID: 21907783
[TBL] [Abstract][Full Text] [Related]
17. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
Ji W; Wang T; Xu Y; An R; Liang K; Wang X
Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the active components, prospective targets, and molecular mechanism of Baihe Zhimu decoction for treating depression using network pharmacology-based analysis.
Wang HQ; Liu HT; Wang L; Min L; Chen B; Li H
J Ethnopharmacol; 2021 Dec; 281():114586. PubMed ID: 34464700
[TBL] [Abstract][Full Text] [Related]
19. Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis.
Wei X; Zhou R; Chen Y; Ma G; Yang Y; Lu C; Xu W; Hu W
Bioorg Chem; 2022 Feb; 119():105519. PubMed ID: 34864624
[TBL] [Abstract][Full Text] [Related]
20. A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.
Li X; Xu X; Wang J; Yu H; Wang X; Yang H; Xu H; Tang S; Li Y; Yang L; Huang L; Wang Y; Yang S
PLoS One; 2012; 7(9):e43918. PubMed ID: 22962593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
